— Know what they know.
Not Investment Advice

RYOIX

Rydex Biotechnology Inv
1W: -2.3% 1M: -4.2% 3M: +1.2% YTD: +24.0% 1Y: +24.4% 3Y: +40.6% 5Y: +8.6%
$93.21
+0.07 (+0.08%)
 
Weekly Expected Move ±2.6%
$88 $91 $93 $96 $98
ETF NASDAQ · AUM $98.4M

Portfolio Health Summary

IS Overall Score
53.1
★★★★★
Altman Z-Score
11.38
Safe
Weight Coverage
92%
of portfolio analyzed
Holdings Matched
69
with fundamental data

InsiderStreet Scorecard

★★★★★ 53.1
Profitability
51.9
Balance Sheet
55.7
Earnings Quality
52.9
Growth
60.0
Value
39.7
Momentum
70.4
Safety
81.2

Top Holdings: Score Breakdown

Risk & Quality Signals

Altman Z-Score
11.38
Safe Zone (>2.99)
Piotroski F-Score
5.0 / 9
Moderate
Beneish M-Score
-0.11
Possible Manipulator
Credit Score
—
Earnings Quality
52.9 / 100

Portfolio Valuation

P/E
38.88x
P/B
8.41x
P/S
5.22x
EV/EBITDA
21.63x
EV/Revenue
8.01x
P/FCF
19.40x
P/OCF
17.61x
PEG
3.38x
Earnings Yield
2.57%
FCF Yield
5.15%
OCF Yield
5.68%
Median P/E
-6.48x

Growth & Shareholder Returns

Year-over-Year Growth

Revenue +31.3%
Net Income +26.9%
EPS +30.7%
FCF +25.4%
EBITDA +33.5%
Op. Income —

Compound Growth Rates

Rev CAGR 3Y +40.6%
Rev CAGR 5Y +32.2%
EPS CAGR 3Y +11.5%
EPS CAGR 5Y +10.6%
FCF CAGR 3Y +8.0%
FCF CAGR 5Y +18.9%
EBITDA CAGR 3Y +9.9%
EBITDA CAGR 5Y +8.7%
Payout Ratio
33.48%
Buyback Yield
1.32%
Dividend Yield
0.49%
Total Shareholder Return
-1.57%

Earnings Stability

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$93.14
Median 1Y
$96.76
5th Pctile
$62.87
95th Pctile
$148.87
Ann. Volatility
25.7%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics
Valuation (12)
MetricValue
Portfolio P/E 38.88
Portfolio P/B 8.41
Portfolio P/S 5.22
EV/EBITDA 21.63
EV/Revenue 8.01
P/FCF 19.40
P/OCF 17.61
PEG 3.38
Earnings Yield 2.57%
FCF Yield 5.15%
OCF Yield 5.68%
Median P/E -6.48
Profitability & Returns (9)
MetricValue
Gross Margin 81.99%
Operating Margin 27.43%
Net Margin 6.20%
FCF Margin 25.10%
ROE 10.44%
ROA 2.72%
ROIC 17.26%
ROCE —
Asset Turnover —
Leverage & Solvency (6)
MetricValue
Debt/Equity 1.49
Debt/Assets 0.40
Net Debt/EBITDA 1.72
Interest Coverage 7.16
Current Ratio 1.28
Quick Ratio 1.07
Efficiency (4)
MetricValue
Asset Turnover —
Inventory Turnover —
Receivables Turnover —
Payables Turnover —
Growth — YoY (6)
MetricValue
Revenue Growth 31.34%
Net Income Growth 26.94%
EPS Growth 30.72%
FCF Growth 25.39%
EBITDA Growth 33.49%
Op. Income Growth —
Growth — CAGR (16)
MetricValue
Revenue CAGR 3Y 40.63%
Revenue CAGR 5Y 32.18%
Revenue CAGR 10Y —
EPS CAGR 3Y 11.51%
EPS CAGR 5Y 10.59%
EPS CAGR 10Y —
FCF CAGR 3Y 8.02%
FCF CAGR 5Y 18.93%
FCF CAGR 10Y —
EBITDA CAGR 3Y 9.94%
EBITDA CAGR 5Y 8.70%
EBITDA CAGR 10Y —
Net Income CAGR 3Y 9.87%
Net Income CAGR 5Y 10.16%
Op. Income CAGR 3Y —
Op. Income CAGR 5Y —
Quality Scores (13)
MetricValue
IS Overall 53.1
IS Profitability 51.9
IS Balance Sheet 55.7
IS Earnings Quality 52.9
IS Growth 60.0
IS Value 39.7
IS Momentum 70.4
IS Safety 81.2
IS Quality 60.9
Altman Z-Score 11.38
Piotroski F-Score 4.98
Beneish M-Score -0.11
Credit Score —
Dividends & Payout (4)
MetricValue
Dividend Yield 0.49%
Payout Ratio 33.48%
Buyback Yield 1.32%
Total Shareholder Return -1.57%
Growth Stability (4)
MetricValue
Revenue Stability 0.770
Earnings Stability 0.479
Earnings Persistence 0.638
Margin Stability 0.769
Medians (3)
MetricValue
Median P/E -6.48
Median P/B 5.57
Median Dividend Yield —
Coverage Meta (3)
MetricValue
Weight Coverage % 92.41%
Holdings Matched 69
Total Holdings 70

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms